Clinical Pharmacists Role in the Management of Hypertension in Jordan
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
|Official Title:||Clinical Pharmacists Role in the Management of Hypertension in Jordan|
- percentage of patients who achieved blood pressure goals specified by the JNC VII at each group [ Time Frame: 6 month ]defined a goal to be achieved if the systolic blood pressure fell below 140 mm Hg and the diastolic blood pressure fell below 90 mm Hg. Or systolic blood pressure fell below 130 mm Hg and the diastolic blood pressure fell below 80 mm Hg if patient was diabetic.
- mean reductions in both systolic and diastolic blood pressure readings [ Time Frame: 6 months ]mean reductions in systolic blood pressure (Systolic blood pressure at enrollment - Systolic blood pressure last follow up visit) and diastolic BP (Diastolic blood pressure at enrollment - Diastolic blood pressure last follow up visit) for both study groups
|Study Start Date:||March 2009|
|Study Completion Date:||November 2009|
|Primary Completion Date:||November 2009 (Final data collection date for primary outcome measure)|
Active Comparator: intervention group
Other: pharmaceutical care services
Patients treatment related problems and therapeutic needs or complains identified by clinical pharmacist and managed collaboratively by both pharmacist and the physician.
No Intervention: control
physician only team
Objective: this study aimed to evaluate clinical pharmacists' role in the management of uncontrolled hypertensive patients in Jordan. Design: single blinded randomized controlled clinical trial. Patients: 253 patients with uncontrolled hypertension specified as higher blood pressure readings than the recommended goals by the seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC VII) at the time of enrollment.
Interventions: patients were randomly allocated to an intervention or control group: 130 and 123 patients, respectively. Patients in both arms were followed up for 6 months. In the intervention group, patients were managed by physician-clinical pharmacist team. In the control group, patients were managed by physician(s) only and were not provided pharmaceutical care services.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01079494
|family medicine clinic JUH|
|Amman, Jordan, 13046|
|Principal Investigator:||Eman Hammad, MSc||University of Jordan/ Faculty of Pharmacy|
|Study Director:||Abla Al bsoul, PhD||University of Jordan/ Faculty of Pharmacy|